Exact Mass: 412.06337560000003
Exact Mass Matches: 412.06337560000003
Found 118 metabolites which its exact mass value is equals to given mass value 412.06337560000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ziprasidone
C21H21ClN4OS (412.11245260000004)
Ziprasidone (marketed as Geodon, Zeldox) was the fifth atypical antipsychotic to gain FDA approval (February 2001). Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania associated with bipolar disorder. [Wikipedia] D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AE - Indole derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ziprasidone (CP-88059), an orally active antipsychotic agent, is a combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone mesylate trihydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].
pyraflufen
C15H13Cl2F3N2O4 (412.02044340000003)
CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9709; ORIGINAL_PRECURSOR_SCAN_NO 9708 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9657; ORIGINAL_PRECURSOR_SCAN_NO 9655 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9632; ORIGINAL_PRECURSOR_SCAN_NO 9630 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9674; ORIGINAL_PRECURSOR_SCAN_NO 9672 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9681; ORIGINAL_PRECURSOR_SCAN_NO 9679 CONFIDENCE standard compound; INTERNAL_ID 404; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9708; ORIGINAL_PRECURSOR_SCAN_NO 9706
Imazosulfuron
C14H13ClN6O5S (412.03566380000007)
Precursor ion, [M-H]-, is a 37Cl-isotopolog ion.; The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
dIDP
dIDP (deoxyinoside diphosphate) is a nucleoside. Deoxyinosine diphosphate appears in the urine of patients with purine metabolism abnormalities in purine nucleoside phosphorylase deficiency(OMIM 164050) [HMDB] dIDP (deoxyinoside diphosphate) is a nucleoside. Deoxyinosine diphosphate appears in the urine of patients with purine metabolism abnormalities in purine nucleoside phosphorylase deficiency(OMIM 164050).
Patientoside A
Patientoside A is found in herbs and spices. Patientoside A is a constituent of the roots of Rumex patientia (patience dock). Constituent of the roots of Rumex patientia (patience dock). Patientoside A is found in herbs and spices.
Zileuton O-glucuronide
Zileuton O-glucuronide is a metabolite of zileuton. Zileuton (trade name ZYFLO) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation. Zileuton is used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names ZYFLO and ZYFLO CR. The original immediate-release formulation of zileuton, known as ZYFLO, is taken four times per day. (Wikipedia)
4,7-Diphenyl-1,10-phenanthrolinesulphonic acid
C24H16N2O3S (412.08815860000004)
4-Amino-5-methylamino-2',7'-difluorescein
Glycogen Phosphorylase Inhibitor
Nitrofenac
C18H18Cl2N2O5 (412.05927180000003)
Thiamphenicol glycinate
C14H18Cl2N2O6S (412.02625880000005)
N-methylwelwitindolinone C isothiocyanate
C22H21ClN2O2S (412.10121960000004)
(E)-2-(3-(3-bromo-4-methoxyphenyl)acrylamido)-5-guanidinopentanoic acid|subereamine A
C16H21BrN4O4 (412.07460860000003)
Ziprasidone
C21H21ClN4OS (412.11245260000004)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AE - Indole derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent CONFIDENCE standard compound; INTERNAL_ID 2747 CONFIDENCE standard compound; INTERNAL_ID 8529 Ziprasidone (CP-88059), an orally active antipsychotic agent, is a combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone mesylate trihydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].
Cys Cys Gly Met
Cys Cys Met Gly
Cys Cys Ser Thr
C13H24N4O7S2 (412.10863539999997)
Cys Cys Thr Ser
C13H24N4O7S2 (412.10863539999997)
Cys Gly Cys Met
Cys Gly Met Cys
Cys Met Cys Gly
Cys Met Gly Cys
Cys Ser Cys Thr
C13H24N4O7S2 (412.10863539999997)
Cys Ser Thr Cys
C13H24N4O7S2 (412.10863539999997)
Cys Thr Cys Ser
C13H24N4O7S2 (412.10863539999997)
Cys Thr Ser Cys
C13H24N4O7S2 (412.10863539999997)
Gly Cys Cys Met
Gly Cys Met Cys
Gly Met Cys Cys
Met Cys Cys Gly
Met Cys Gly Cys
Met Gly Cys Cys
Ser Cys Cys Thr
C13H24N4O7S2 (412.10863539999997)
Ser Cys Thr Cys
C13H24N4O7S2 (412.10863539999997)
Ser Thr Cys Cys
C13H24N4O7S2 (412.10863539999997)
Thr Cys Cys Ser
C13H24N4O7S2 (412.10863539999997)
Thr Cys Ser Cys
C13H24N4O7S2 (412.10863539999997)
Thr Ser Cys Cys
C13H24N4O7S2 (412.10863539999997)
Patientoside A
(1-METHYL-1H-PYRROL-2-YL)METHYLAMINE
C23H26BrP (412.09553860000005)
(3-amino-6-phenyl-4-thiophen-2-ylthieno[2,3-b]pyridin-2-yl)-phenylmethanone
C24H16N2OS2 (412.07040059999997)
1-(Phenylsulfonyl)indole-2-boronic acid MIDA ester,1-(Phenylsulfonyl)indole-2-boronic acid,Methyliminodiacetic acid anhydride
C19H17BN2O6S (412.09003320000005)
isoamyltriphenylphosphonium bromide
C23H26BrP (412.09553860000005)
9H-Purine,6-chloro-9-(2,3,5-tri-O-acetyl-b-D-ribofuranosyl)-
Pentyltriphenylphosphonium bromide
C23H26BrP (412.09553860000005)
3-nitro-4-(2-(3-phenoxybenzylidene)hydrazinyl)benzenesulfonamide
4-{3-Chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-hydroxy-6-quinolinecarboxamide
Ethyl 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylate acetate (1:1)
ethyl 6-broMo-1,5-diMethyl-2-(2-nitroethyl)-1H-indole-3-carboxylate coMpound with Methanedione (1:1)
methyl 3-(4-methylsulfonylphenoxy)-5-phenylmethoxybenzoate
C22H20O6S (412.09805400000005)
2-[[4-[3-(4,5-dichloro-2-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]ethanol
C18H18Cl2N2O3S (412.0415138000001)
[4,4,5,5,6,7,7,7-octafluoro-2-hydroxy-6-(trifluoromethyl)heptyl] 2-methylprop-2-enoate
Chitobiose
C12H26Cl2N2O9 (412.10152860000005)
Chitobiose is a dimer of beta-1,4-linked glucosamine units. There is ambiguity as to which structure the name refers, owing to the method by which it was first isolated. [HMDB]
2-(2,2-Dichloroacetamido)-3-hydroxy-3-[4-(methanesulfonyl)phenyl]propyl glycinate
C14H18Cl2N2O6S (412.02625880000005)
2-Furanyl-[4-(4-phenoxyphenyl)sulfonyl-1-piperazinyl]methanone
C21H20N2O5S (412.10928700000005)
Butyl 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl carbonate
N-(2-pyridin-3-ylpyrimidin-4-yl)-3,5-bis(trifluoromethyl)benzamide
(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)
1-Phosphono-4-[4-propyl-1,1-biphenyl-4-yl]-1-butanesulfonic acid
C19H25O6PS (412.1109400000001)
Subereamine A
C16H21BrN4O4 (412.07460860000003)
A natural product found in Suberea mollis.
(E)-N-[N-(5-Methyl-3-phenyl-isoxazole-4-carbonyl)-hydrazinocarbothioyl]-3-thiophen-2-yl-acrylamide
C19H16N4O3S2 (412.06637859999995)
3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxybenzoic acid
2-[3-[2-furanyl(oxo)methyl]-1-indolyl]-N-[2-(trifluoromethyl)phenyl]acetamide
C22H15F3N2O3 (412.10347160000003)
methyl 8-[(2E)-2-[(6-bromo-1,3-benzodioxol-5-yl)methylidene]hydrazinyl]-8-oxooctanoate
C17H21BrN2O5 (412.06337560000003)
(3S,4R,5S)-4-(tert-Butyldimethylsilyloxy)-1,1-dibromo-3,5-dimethyl-1-heptene
2-Deoxyinosine-5-diphosphate
A deoxyinosine phosphate compound having a diphosphate group at the 5-position.
(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)
Dicarboxylate anion of (7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate acid.
A 839977
A 839977 is a P2X7 selective antagonist; it blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20 nM, 42 nM and 150 nM respectively) and reduces inflammatory and neuropathic pain in animal models; the antihyperalgesic effects of P2X7 receptor blockade are mediated by blocking the release of IL-1beta[1].
Chitobiose (dihydrochloride)
C12H26Cl2N2O9 (412.10152860000005)
Chitobiose dihydrochloride, a chitosan oligosaccharide, is a dimer of β-1,4-linked glucosamine units[1].